Cardioprotective Effect of Intravenous Nicorandil in Patients With Successful Reperfusion for Acute Myocardial Infarction
Authors:
Open Access
- 1 January 1998
- journal article
- clinical trial
- Published by Japanese Circulation Society in Japanese Circulation Journal
- Vol. 62 (3) , 183-189
Abstract
This study was designed to assess the cardioprotective effect of intravenous nicorandil, a potassium channel opener, in preventing reperfusion injury in acute myocardial infarction. Seventy patients were treated with placebo or nicorandil concomitant with reperfusion therapy in a prospective, randomized, double-blind fashion within 6 h after the onset of acute myocardial infarction. Nicorandil was administered before reperfusion as a 2-mg boIus iv injection followed by continuous infusion of 2-6 mg/h for the next 3 h. Thirty-six patients (17 in the placebo group, 19 in the nicorandil group) who demonstrated both complete occlusion of an infarct-related vessel before treatment and successful reperfusion were included in the final analysis. No significant changes in left ventricular ejection fraction were observed between the immediate and chronic phases in each group. In the analysis of regional ventricular function, the placebo group did not show any significant change in regional chord shortening (26.8±8.2 vs 24.3±7.3%, NS) or hypocontractile perimeter (36.4±28.2% vs 28.3±24.8%, NS) between immediate and chronic phase left ventriculograms. In contrast, in the nicorandil group, a significant increase in regional chord shortening (21.5±11.0% vs 25.8±11.3%, pJpn Circ J 1998; 62: 183 - 189)Keywords
This publication has 28 references indexed in Scilit:
- Does reperfusion injury exist in humans?JACC, 1993
- Reperfusion injury and its pharmacologic modification.Circulation, 1989
- Reduction of Size of Myocardial Infarction with Nicorandil, a New Antianginal Drug, After Coronary Artery Occlusion in DogsJournal of Cardiovascular Pharmacology, 1988
- Salutary action of nicorandil, a new antianginal drug, on myocardial metabolism during ischemia and on postischemic function in a canine preparation of brief, repetitive coronary artery occlusions: comparison with isosorbide dinitrate.Circulation, 1987
- The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.Circulation, 1987
- Effects of Nicorandil on Coronary Hemodynamics in Ischemic Heart DiseaseJournal of Cardiovascular Pharmacology, 1987
- Determinants of left ventricular aneurysm formation after anterior myocardial infarction: A clinical and angiographic studyJACC, 1986
- Improved Recovery of Myocardial Segment Function Following a Short Coronary Occlusion in Dogs by Nicorandil, a Potential New Antianginal Agent, and NifedipineJournal of Cardiovascular Pharmacology, 1985
- Effects of Nicorandil and Nifedipine on Protection of Ischemic MyocardiumJournal of Cardiovascular Pharmacology, 1984
- Cyclic GMP as Possible Mediator of Coronary Arterial Relaxation by Nicorandil (SG-75)Journal of Cardiovascular Pharmacology, 1983